Global and China Pharmaceuticals and Biotechnology R&D Market Size, Status and Forecast 2021-2027

SKU ID : QYR-19192057 | Publishing Date : 21-Sep-2021 | No. of pages : 126

Detailed TOC of Global and China Pharmaceuticals and Biotechnology R&D Market Size, Status and Forecast 2021-2027

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Pharmaceuticals and Biotechnology R&D Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Drug
        1.2.3 Medical Equipment
        1.2.4 Vaccine
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Pharmaceuticals and Biotechnology R&D Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Homecare
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Pharmaceuticals and Biotechnology R&D Market Perspective (2016-2027)
    2.2 Pharmaceuticals and Biotechnology R&D Growth Trends by Regions
        2.2.1 Pharmaceuticals and Biotechnology R&D Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Pharmaceuticals and Biotechnology R&D Historic Market Share by Regions (2016-2021)
        2.2.3 Pharmaceuticals and Biotechnology R&D Forecasted Market Size by Regions (2022-2027)
    2.3 Pharmaceuticals and Biotechnology R&D Industry Dynamic
        2.3.1 Pharmaceuticals and Biotechnology R&D Market Trends
        2.3.2 Pharmaceuticals and Biotechnology R&D Market Drivers
        2.3.3 Pharmaceuticals and Biotechnology R&D Market Challenges
        2.3.4 Pharmaceuticals and Biotechnology R&D Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Pharmaceuticals and Biotechnology R&D Players by Revenue
        3.1.1 Global Top Pharmaceuticals and Biotechnology R&D Players by Revenue (2016-2021)
        3.1.2 Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Players (2016-2021)
    3.2 Global Pharmaceuticals and Biotechnology R&D Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Pharmaceuticals and Biotechnology R&D Revenue
    3.4 Global Pharmaceuticals and Biotechnology R&D Market Concentration Ratio
        3.4.1 Global Pharmaceuticals and Biotechnology R&D Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Pharmaceuticals and Biotechnology R&D Revenue in 2020
    3.5 Pharmaceuticals and Biotechnology R&D Key Players Head office and Area Served
    3.6 Key Players Pharmaceuticals and Biotechnology R&D Product Solution and Service
    3.7 Date of Enter into Pharmaceuticals and Biotechnology R&D Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmaceuticals and Biotechnology R&D Breakdown Data by Type
    4.1 Global Pharmaceuticals and Biotechnology R&D Historic Market Size by Type (2016-2021)
    4.2 Global Pharmaceuticals and Biotechnology R&D Forecasted Market Size by Type (2022-2027)

5 Pharmaceuticals and Biotechnology R&D Breakdown Data by Application
    5.1 Global Pharmaceuticals and Biotechnology R&D Historic Market Size by Application (2016-2021)
    5.2 Global Pharmaceuticals and Biotechnology R&D Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Pharmaceuticals and Biotechnology R&D Market Size (2016-2027)
    6.2 North America Pharmaceuticals and Biotechnology R&D Market Size by Type
        6.2.1 North America Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2021)
        6.2.2 North America Pharmaceuticals and Biotechnology R&D Market Size by Type (2022-2027)
        6.2.3 North America Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2027)
    6.3 North America Pharmaceuticals and Biotechnology R&D Market Size by Application
        6.3.1 North America Pharmaceuticals and Biotechnology R&D Market Size by Application (2016-2021)
        6.3.2 North America Pharmaceuticals and Biotechnology R&D Market Size by Application (2022-2027)
        6.3.3 North America Pharmaceuticals and Biotechnology R&D Market Size by Application (2016-2027)
    6.4 North America Pharmaceuticals and Biotechnology R&D Market Size by Country
        6.4.1 North America Pharmaceuticals and Biotechnology R&D Market Size by Country (2016-2021)
        6.4.2 North America Pharmaceuticals and Biotechnology R&D Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Pharmaceuticals and Biotechnology R&D Market Size (2016-2027)
    7.2 Europe Pharmaceuticals and Biotechnology R&D Market Size by Type
        7.2.1 Europe Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2021)
        7.2.2 Europe Pharmaceuticals and Biotechnology R&D Market Size by Type (2022-2027)
        7.2.3 Europe Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2027)
    7.3 Europe Pharmaceuticals and Biotechnology R&D Market Size by Application
        7.3.1 Europe Pharmaceuticals and Biotechnology R&D Market Size by Application (2016-2021)
        7.3.2 Europe Pharmaceuticals and Biotechnology R&D Market Size by Application (2022-2027)
        7.3.3 Europe Pharmaceuticals and Biotechnology R&D Market Size by Application (2016-2027)
    7.4 Europe Pharmaceuticals and Biotechnology R&D Market Size by Country
        7.4.1 Europe Pharmaceuticals and Biotechnology R&D Market Size by Country (2016-2021)
        7.4.2 Europe Pharmaceuticals and Biotechnology R&D Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size (2016-2027)
    8.2 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Type
        8.2.1 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2027)
    8.3 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Application
        8.3.1 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Application (2016-2027)
    8.4 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Region
        8.4.1 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Pharmaceuticals and Biotechnology R&D Market Size (2016-2027)
    9.2 Latin America Pharmaceuticals and Biotechnology R&D Market Size by Type
        9.2.1 Latin America Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2021)
        9.2.2 Latin America Pharmaceuticals and Biotechnology R&D Market Size by Type (2022-2027)
        9.2.3 Latin America Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2027)
    9.3 Latin America Pharmaceuticals and Biotechnology R&D Market Size by Application
        9.3.1 Latin America Pharmaceuticals and Biotechnology R&D Market Size by Application (2016-2021)
        9.3.2 Latin America Pharmaceuticals and Biotechnology R&D Market Size by Application (2022-2027)
        9.3.3 Latin America Pharmaceuticals and Biotechnology R&D Market Size by Application (2016-2027)
    9.4 Latin America Pharmaceuticals and Biotechnology R&D Market Size by Country
        9.4.1 Latin America Pharmaceuticals and Biotechnology R&D Market Size by Country (2016-2021)
        9.4.2 Latin America Pharmaceuticals and Biotechnology R&D Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size (2016-2027)
    10.2 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Type
        10.2.1 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2027)
    10.3 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Application
        10.3.1 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Application (2016-2027)
    10.4 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Country
        10.4.1 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 ROCHE
        11.1.1 ROCHE Company Details
        11.1.2 ROCHE Business Overview
        11.1.3 ROCHE Pharmaceuticals and Biotechnology R&D Introduction
        11.1.4 ROCHE Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
        11.1.5 ROCHE Recent Development
    11.2 JOHNSON & JOHNSON
        11.2.1 JOHNSON & JOHNSON Company Details
        11.2.2 JOHNSON & JOHNSON Business Overview
        11.2.3 JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R&D Introduction
        11.2.4 JOHNSON & JOHNSON Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
        11.2.5 JOHNSON & JOHNSON Recent Development
    11.3 MERCK
        11.3.1 MERCK Company Details
        11.3.2 MERCK Business Overview
        11.3.3 MERCK Pharmaceuticals and Biotechnology R&D Introduction
        11.3.4 MERCK Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
        11.3.5 MERCK Recent Development
    11.4 NOVARTIS
        11.4.1 NOVARTIS Company Details
        11.4.2 NOVARTIS Business Overview
        11.4.3 NOVARTIS Pharmaceuticals and Biotechnology R&D Introduction
        11.4.4 NOVARTIS Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
        11.4.5 NOVARTIS Recent Development
    11.5 PFIZER
        11.5.1 PFIZER Company Details
        11.5.2 PFIZER Business Overview
        11.5.3 PFIZER Pharmaceuticals and Biotechnology R&D Introduction
        11.5.4 PFIZER Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
        11.5.5 PFIZER Recent Development
    11.6 SANOFI
        11.6.1 SANOFI Company Details
        11.6.2 SANOFI Business Overview
        11.6.3 SANOFI Pharmaceuticals and Biotechnology R&D Introduction
        11.6.4 SANOFI Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
        11.6.5 SANOFI Recent Development
    11.7 BAYER
        11.7.1 BAYER Company Details
        11.7.2 BAYER Business Overview
        11.7.3 BAYER Pharmaceuticals and Biotechnology R&D Introduction
        11.7.4 BAYER Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
        11.7.5 BAYER Recent Development
    11.8 BRISTOL-MYERS SQUIBB
        11.8.1 BRISTOL-MYERS SQUIBB Company Details
        11.8.2 BRISTOL-MYERS SQUIBB Business Overview
        11.8.3 BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R&D Introduction
        11.8.4 BRISTOL-MYERS SQUIBB Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
        11.8.5 BRISTOL-MYERS SQUIBB Recent Development
    11.9 ASTRAZENECA
        11.9.1 ASTRAZENECA Company Details
        11.9.2 ASTRAZENECA Business Overview
        11.9.3 ASTRAZENECA Pharmaceuticals and Biotechnology R&D Introduction
        11.9.4 ASTRAZENECA Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
        11.9.5 ASTRAZENECA Recent Development
    11.10 GLAXOSMITHKLINE
        11.10.1 GLAXOSMITHKLINE Company Details
        11.10.2 GLAXOSMITHKLINE Business Overview
        11.10.3 GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R&D Introduction
        11.10.4 GLAXOSMITHKLINE Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
        11.10.5 GLAXOSMITHKLINE Recent Development
    11.11 ABBVIE
        11.11.1 ABBVIE Company Details
        11.11.2 ABBVIE Business Overview
        11.11.3 ABBVIE Pharmaceuticals and Biotechnology R&D Introduction
        11.11.4 ABBVIE Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
        11.11.5 ABBVIE Recent Development
    11.12 ELI LILLY
        11.12.1 ELI LILLY Company Details
        11.12.2 ELI LILLY Business Overview
        11.12.3 ELI LILLY Pharmaceuticals and Biotechnology R&D Introduction
        11.12.4 ELI LILLY Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
        11.12.5 ELI LILLY Recent Development
    11.13 BOEHRINGER SOHN
        11.13.1 BOEHRINGER SOHN Company Details
        11.13.2 BOEHRINGER SOHN Business Overview
        11.13.3 BOEHRINGER SOHN Pharmaceuticals and Biotechnology R&D Introduction
        11.13.4 BOEHRINGER SOHN Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
        11.13.5 BOEHRINGER SOHN Recent Development
    11.14 AMGEN
        11.14.1 AMGEN Company Details
        11.14.2 AMGEN Business Overview
        11.14.3 AMGEN Pharmaceuticals and Biotechnology R&D Introduction
        11.14.4 AMGEN Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
        11.14.5 AMGEN Recent Development
    11.15 GILEAD SCIENCES
        11.15.1 GILEAD SCIENCES Company Details
        11.15.2 GILEAD SCIENCES Business Overview
        11.15.3 GILEAD SCIENCES Pharmaceuticals and Biotechnology R&D Introduction
        11.15.4 GILEAD SCIENCES Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
        11.15.5 GILEAD SCIENCES Recent Development
    11.16 TAKEDA PHARMACEUTICAL
        11.16.1 TAKEDA PHARMACEUTICAL Company Details
        11.16.2 TAKEDA PHARMACEUTICAL Business Overview
        11.16.3 TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R&D Introduction
        11.16.4 TAKEDA PHARMACEUTICAL Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
        11.16.5 TAKEDA PHARMACEUTICAL Recent Development
    11.17 NOVO NORDISK
        11.17.1 NOVO NORDISK Company Details
        11.17.2 NOVO NORDISK Business Overview
        11.17.3 NOVO NORDISK Pharmaceuticals and Biotechnology R&D Introduction
        11.17.4 NOVO NORDISK Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
        11.17.5 NOVO NORDISK Recent Development
    11.18 BIOGEN
        11.18.1 BIOGEN Company Details
        11.18.2 BIOGEN Business Overview
        11.18.3 BIOGEN Pharmaceuticals and Biotechnology R&D Introduction
        11.18.4 BIOGEN Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
        11.18.5 BIOGEN Recent Development
    11.18 ABBOTT
        .1 ABBOTT Company Details
        .2 ABBOTT Business Overview
        .3 ABBOTT Pharmaceuticals and Biotechnology R&D Introduction
        .4 ABBOTT Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
        .5 ABBOTT Recent Development
    11.20 ASTELLAS PHARMA
        11.20.1 ASTELLAS PHARMA Company Details
        11.20.2 ASTELLAS PHARMA Business Overview
        11.20.3 ASTELLAS PHARMA Pharmaceuticals and Biotechnology R&D Introduction
        11.20.4 ASTELLAS PHARMA Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
        11.20.5 ASTELLAS PHARMA Recent Development
    11.21 TEVA PHARMACEUTICAL INDUSTRIES
        11.21.1 TEVA PHARMACEUTICAL INDUSTRIES Company Details
        11.21.2 TEVA PHARMACEUTICAL INDUSTRIES Business Overview
        11.21.3 TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R&D Introduction
        11.21.4 TEVA PHARMACEUTICAL INDUSTRIES Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
        11.21.5 TEVA PHARMACEUTICAL INDUSTRIES Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Figures, Tables and Charts Available in Global and China Pharmaceuticals and Biotechnology R&D Market Size, Status and Forecast 2021-2027

List of Tables
    Table 1. Global Pharmaceuticals and Biotechnology R&D Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Drug
    Table 3. Key Players of Medical Equipment
    Table 4. Key Players of Vaccine
    Table 5. Key Players of Others
    Table 6. Global Pharmaceuticals and Biotechnology R&D Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Pharmaceuticals and Biotechnology R&D Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Pharmaceuticals and Biotechnology R&D Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Pharmaceuticals and Biotechnology R&D Market Share by Regions (2016-2021)
    Table 10. Global Pharmaceuticals and Biotechnology R&D Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Pharmaceuticals and Biotechnology R&D Market Share by Regions (2022-2027)
    Table 12. Pharmaceuticals and Biotechnology R&D Market Trends
    Table 13. Pharmaceuticals and Biotechnology R&D Market Drivers
    Table 14. Pharmaceuticals and Biotechnology R&D Market Challenges
    Table 15. Pharmaceuticals and Biotechnology R&D Market Restraints
    Table 16. Global Pharmaceuticals and Biotechnology R&D Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Pharmaceuticals and Biotechnology R&D Market Share by Players (2016-2021)
    Table 18. Global Top Pharmaceuticals and Biotechnology R&D Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceuticals and Biotechnology R&D as of 2020)
    Table 19. Ranking of Global Top Pharmaceuticals and Biotechnology R&D Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Pharmaceuticals and Biotechnology R&D Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Pharmaceuticals and Biotechnology R&D Product Solution and Service
    Table 23. Date of Enter into Pharmaceuticals and Biotechnology R&D Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Type (2016-2021)
    Table 27. Global Pharmaceuticals and Biotechnology R&D Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Pharmaceuticals and Biotechnology R&D Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Application (2016-2021)
    Table 31. Global Pharmaceuticals and Biotechnology R&D Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Pharmaceuticals and Biotechnology R&D Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Pharmaceuticals and Biotechnology R&D Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Pharmaceuticals and Biotechnology R&D Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Pharmaceuticals and Biotechnology R&D Market Size by Country (2016-2021) & (US$ Million)
    Table 38. North America Pharmaceuticals and Biotechnology R&D Market Size by Country (2022-2027) & (US$ Million)
    Table 39. Europe Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Pharmaceuticals and Biotechnology R&D Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Pharmaceuticals and Biotechnology R&D Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Pharmaceuticals and Biotechnology R&D Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Pharmaceuticals and Biotechnology R&D Market Size by Country (2016-2021) & (US$ Million)
    Table 44. Europe Pharmaceuticals and Biotechnology R&D Market Size by Country (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Region (2016-2021) & (US$ Million)
    Table 50. Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Region (2022-2027) & (US$ Million)
    Table 51. Latin America Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Pharmaceuticals and Biotechnology R&D Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Pharmaceuticals and Biotechnology R&D Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Pharmaceuticals and Biotechnology R&D Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Pharmaceuticals and Biotechnology R&D Market Size by Country (2016-2021) & (US$ Million)
    Table 56. Latin America Pharmaceuticals and Biotechnology R&D Market Size by Country (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Country (2016-2021) & (US$ Million)
    Table 62. Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Country (2022-2027) & (US$ Million)
    Table 63. ROCHE Company Details
    Table 64. ROCHE Business Overview
    Table 65. ROCHE Pharmaceuticals and Biotechnology R&D Product
    Table 66. ROCHE Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million)
    Table 67. ROCHE Recent Development
    Table 68. JOHNSON & JOHNSON Company Details
    Table 69. JOHNSON & JOHNSON Business Overview
    Table 70. JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R&D Product
    Table 71. JOHNSON & JOHNSON Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million)
    Table 72. JOHNSON & JOHNSON Recent Development
    Table 73. MERCK Company Details
    Table 74. MERCK Business Overview
    Table 75. MERCK Pharmaceuticals and Biotechnology R&D Product
    Table 76. MERCK Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million)
    Table 77. MERCK Recent Development
    Table 78. NOVARTIS Company Details
    Table 79. NOVARTIS Business Overview
    Table 80. NOVARTIS Pharmaceuticals and Biotechnology R&D Product
    Table 81. NOVARTIS Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million)
    Table 82. NOVARTIS Recent Development
    Table 83. PFIZER Company Details
    Table 84. PFIZER Business Overview
    Table 85. PFIZER Pharmaceuticals and Biotechnology R&D Product
    Table 86. PFIZER Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million)
    Table 87. PFIZER Recent Development
    Table 88. SANOFI Company Details
    Table 89. SANOFI Business Overview
    Table 90. SANOFI Pharmaceuticals and Biotechnology R&D Product
    Table 91. SANOFI Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million)
    Table 92. SANOFI Recent Development
    Table 93. BAYER Company Details
    Table 94. BAYER Business Overview
    Table 95. BAYER Pharmaceuticals and Biotechnology R&D Product
    Table 96. BAYER Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million)
    Table 97. BAYER Recent Development
    Table 98. BRISTOL-MYERS SQUIBB Company Details
    Table 99. BRISTOL-MYERS SQUIBB Business Overview
    Table 100. BRISTOL-MYERS SQUIBB Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million)
    Table 101. BRISTOL-MYERS SQUIBB Recent Development
    Table 102. ASTRAZENECA Company Details
    Table 103. ASTRAZENECA Business Overview
    Table 104. ASTRAZENECA Pharmaceuticals and Biotechnology R&D Product
    Table 105. ASTRAZENECA Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million)
    Table 106. ASTRAZENECA Recent Development
    Table 107. GLAXOSMITHKLINE Company Details
    Table 108. GLAXOSMITHKLINE Business Overview
    Table 109. GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R&D Product
    Table 110. GLAXOSMITHKLINE Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million)
    Table 111. GLAXOSMITHKLINE Recent Development
    Table 112. ABBVIE Company Details
    Table 113. ABBVIE Business Overview
    Table 114. ABBVIE Pharmaceuticals and Biotechnology R&D Product
    Table 115. ABBVIE Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million)
    Table 116. ABBVIE Recent Development
    Table 117. ELI LILLY Company Details
    Table 118. ELI LILLY Business Overview
    Table 119. ELI LILLY Pharmaceuticals and Biotechnology R&D Product
    Table 120. ELI LILLY Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million)
    Table 121. ELI LILLY Recent Development
    Table 122. BOEHRINGER SOHN Company Details
    Table 123. BOEHRINGER SOHN Business Overview
    Table 124. BOEHRINGER SOHN Pharmaceuticals and Biotechnology R&D Product
    Table 125. BOEHRINGER SOHN Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million)
    Table 126. BOEHRINGER SOHN Recent Development
    Table 127. AMGEN Company Details
    Table 128. AMGEN Business Overview
    Table 129. AMGEN Pharmaceuticals and Biotechnology R&D Product
    Table 130. AMGEN Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million)
    Table 131. AMGEN Recent Development
    Table 132. GILEAD SCIENCES Company Details
    Table 133. GILEAD SCIENCES Business Overview
    Table 134. GILEAD SCIENCES Pharmaceuticals and Biotechnology R&D Product
    Table 135. GILEAD SCIENCES Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million)
    Table 136. GILEAD SCIENCES Recent Development
    Table 137. TAKEDA PHARMACEUTICAL Company Details
    Table 138. TAKEDA PHARMACEUTICAL Business Overview
    Table 139. TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R&D Product
    Table 140. TAKEDA PHARMACEUTICAL Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million)
    Table 141. TAKEDA PHARMACEUTICAL Recent Development
    Table 142. NOVO NORDISK Company Details
    Table 143. NOVO NORDISK Business Overview
    Table 144. NOVO NORDISK Pharmaceuticals and Biotechnology R&D Product
    Table 145. NOVO NORDISK Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million)
    Table 146. NOVO NORDISK Recent Development
    Table 147. BIOGEN Company Details
    Table 148. BIOGEN Business Overview
    Table 149. BIOGEN Pharmaceuticals and Biotechnology R&D Product
    Table 150. BIOGEN Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million)
    Table 151. BIOGEN Recent Development
    Table 152. ABBOTT Company Details
    Table 153. ABBOTT Business Overview
    Table 154. ABBOTT Pharmaceuticals and Biotechnology R&D Product
    Table 155. ABBOTT Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million)
    Table 156. ABBOTT Recent Development
    Table 157. ASTELLAS PHARMA Company Details
    Table 158. ASTELLAS PHARMA Business Overview
    Table 159. ASTELLAS PHARMA Pharmaceuticals and Biotechnology R&D Product
    Table 160. ASTELLAS PHARMA Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million)
    Table 161. ASTELLAS PHARMA Recent Development
    Table 162. TEVA PHARMACEUTICAL INDUSTRIES Company Details
    Table 163. TEVA PHARMACEUTICAL INDUSTRIES Business Overview
    Table 164. TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R&D Product
    Table 165. TEVA PHARMACEUTICAL INDUSTRIES Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million)
    Table 166. TEVA PHARMACEUTICAL INDUSTRIES Recent Development
    Table 167. Research Programs/Design for This Report
    Table 168. Key Data Information from Secondary Sources
    Table 169. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Pharmaceuticals and Biotechnology R&D Market Share by Type: 2020 VS 2027
    Figure 2. Drug Features
    Figure 3. Medical Equipment Features
    Figure 4. Vaccine Features
    Figure 5. Others Features
    Figure 6. Global Pharmaceuticals and Biotechnology R&D Market Share by Application: 2020 VS 2027
    Figure 7. Hospital Case Studies
    Figure 8. Clinic Case Studies
    Figure 9. Homecare Case Studies
    Figure 10. Others Case Studies
    Figure 11. Pharmaceuticals and Biotechnology R&D Report Years Considered
    Figure 12. Global Pharmaceuticals and Biotechnology R&D Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Pharmaceuticals and Biotechnology R&D Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Pharmaceuticals and Biotechnology R&D Market Share by Regions: 2020 VS 2027
    Figure 15. Global Pharmaceuticals and Biotechnology R&D Market Share by Regions (2022-2027)
    Figure 16. Global Pharmaceuticals and Biotechnology R&D Market Share by Players in 2020
    Figure 17. Global Top Pharmaceuticals and Biotechnology R&D Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceuticals and Biotechnology R&D as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Pharmaceuticals and Biotechnology R&D Revenue in 2020
    Figure 19. Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Type (2016-2021)
    Figure 20. Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Type (2022-2027)
    Figure 21. North America Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Pharmaceuticals and Biotechnology R&D Market Share by Type (2016-2027)
    Figure 23. North America Pharmaceuticals and Biotechnology R&D Market Share by Application (2016-2027)
    Figure 24. North America Pharmaceuticals and Biotechnology R&D Market Share by Country (2016-2027)
    Figure 25. United States Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Pharmaceuticals and Biotechnology R&D Market Share by Type (2016-2027)
    Figure 29. Europe Pharmaceuticals and Biotechnology R&D Market Share by Application (2016-2027)
    Figure 30. Europe Pharmaceuticals and Biotechnology R&D Market Share by Country (2016-2027)
    Figure 31. Germany Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Share by Region (2016-2027)
    Figure 41. China Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Pharmaceuticals and Biotechnology R&D Market Share by Type (2016-2027)
    Figure 49. Latin America Pharmaceuticals and Biotechnology R&D Market Share by Application (2016-2027)
    Figure 50. Latin America Pharmaceuticals and Biotechnology R&D Market Share by Country (2016-2027)
    Figure 51. Mexico Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Share by Country (2016-2027)
    Figure 57. Turkey Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. ROCHE Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
    Figure 61. JOHNSON & JOHNSON Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
    Figure 62. MERCK Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
    Figure 63. NOVARTIS Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
    Figure 64. PFIZER Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
    Figure 65. SANOFI Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
    Figure 66. BAYER Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
    Figure 67. BRISTOL-MYERS SQUIBB Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
    Figure 68. ASTRAZENECA Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
    Figure 69. GLAXOSMITHKLINE Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
    Figure 70. ABBVIE Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
    Figure 71. ELI LILLY Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
    Figure 72. BOEHRINGER SOHN Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
    Figure 73. AMGEN Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
    Figure 74. GILEAD SCIENCES Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
    Figure 75. TAKEDA PHARMACEUTICAL Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
    Figure 76. NOVO NORDISK Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
    Figure 77. BIOGEN Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
    Figure 78. ABBOTT Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
    Figure 79. ASTELLAS PHARMA Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
    Figure 80. TEVA PHARMACEUTICAL INDUSTRIES Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021)
    Figure 81. Bottom-up and Top-down Approaches for This Report
    Figure 82. Data Triangulation
    Figure 83. Key Executives Interviewed

Keyplayers in Global and China Pharmaceuticals and Biotechnology R&D Market Size, Status and Forecast 2021-2027

ROCHE
JOHNSON & JOHNSON
MERCK
NOVARTIS
PFIZER
SANOFI
BAYER
BRISTOL-MYERS SQUIBB
ASTRAZENECA
GLAXOSMITHKLINE
ABBVIE
ELI LILLY
BOEHRINGER SOHN
AMGEN
GILEAD SCIENCES
TAKEDA PHARMACEUTICAL
NOVO NORDISK
BIOGEN
ABBOTT
ASTELLAS PHARMA
TEVA PHARMACEUTICAL INDUSTRIES

REQUEST SUMMARY

Request Sample

Pre-order Enquiry

Request Discount

Contact Information

24/7 Research Support

Phone: +1 424 253 0807

[email protected]